Back to Freestone Grove Partners LP Freestone Grove Partners LP

SUPNSUPN
2 quarters

Position history for Freestone Grove Partners LPFreestone Grove Partners LP's holdings in SUPERNUS PHARMACEUTICALS

Freestone Grove Partners LP holds 641,319 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $33.1M as of 2026-Q1. The position was increased (+226.7% shares). SUPN represents 0.2% of Freestone Grove Partners LP's portfolio.

Current Value

$33.1M

Current Shares

641,319

Total Value Change

+$23.4M

Total Shares Change

+445,001

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
641,319
+226.7%
$33.1M0.2%$54.56
56
2025-Q4
New
196,318
-
$9.8M0.1%$49.89
38

Other major holders of SUPN: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used